Companies / Mexico
Merck, Pfizer Get Mexican Approvals
August 2006 | Product LaunchUS drug giant Pfizer is to market Factive (gemifloxacin), an anti-infective developed by compatriot firm Oscient, in Mexico. The drug is indicated as a five-day therapy for three diseases including pneumonia. Pfizer has faced problems with rival copies of its blockbuster antibiotic azithromycin in Mexico, and the drug's patent has expired in the
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
